Janney Montgomery Scott Reiterates Buy on Flexion Therapeutics (FLXN) Following ANIK Announcement Jun 20, 2018 07:28AM
Flexion Therapeutics (FLXN) PT Lowered to $30 at Janney; Q Code a Near Term Positive Apr 4, 2018 04:24PM
Flexion Therapeutics (FLXN) PT Lowered to $31 at Janney Montgomery Scott Nov 7, 2017 07:32AM
Flexion Therapeutics (FLXN) FVE Raised to $35 at Janney Montgomery Scott Following Investor Day; Positive Development on FX101, 'Improvement on Zilretta' Jul 11, 2017 06:33AM
Janney Montgomery Scott Maintains Buy Rating and $30 PT on Flexion Therapeutics (FLXN); Preparing for 4Q17 Zilretta Launch Mar 10, 2017 06:39AM


Jun 30, 2016 12:11PM Ampio (AMPE) Failure Another Positive for Flexion Therapeutics (FLXN) - Janney Montgomery Scott
Jun 8, 2016 09:04AM Flexion Therapeutics (FLXN) Prices 5.5M Common Stock Offering at $14
Jun 8, 2016 09:00AM Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
May 27, 2016 06:43AM Flexion Therapeutics (FLXN): Greenlights Zilretta NDA Early After FDA Nod - Janney Montgomery Scott
Dec 12, 2014 07:16AM Flexion Therapeutics (FLXN) Prices Larger 5.04M Common Offering at $17/Share
Dec 8, 2014 04:07PM Flexion Therapeutics (FLXN) Announces 3.5M Common Offering
Mar 19, 2014 04:41PM Janney Starts Flexion Therapeutics (FLXN) at Buy
Feb 12, 2014 11:00AM Flexion Therapeutics (FLXN) IPO Ramps 20% Higher